<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00119470</url>
  </required_header>
  <id_info>
    <org_study_id>2004/276</org_study_id>
    <nct_id>NCT00119470</nct_id>
  </id_info>
  <brief_title>EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer</brief_title>
  <official_title>EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial examines the role of EUS-FNA (Oesophageal Endoscopic Ultrasound with Fine Needle&#xD;
      Aspiration) as an endoscopic technique for the mediastinal staging of patients with lung&#xD;
      cancer.&#xD;
&#xD;
      Patients will be randomized to either conventional surgical technique or EUS-FNA.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2005</start_date>
  <completion_date type="Actual">February 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of surgical interventions avoided</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy of EUS-FNA for mediastinal staging of lung cancer</measure>
  </secondary_outcome>
  <enrollment>40</enrollment>
  <condition>Lung Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EUS-FNA</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Surgical Technique</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with histological or cytological proof of non small cell lung cancer (NSCLC)&#xD;
             or with a high clinical suspicion for lung cancer (but without pathologically&#xD;
             confirmed diagnosis from the bronchoscopy or CT guided transthoracal biopsies) in whom&#xD;
             the next step is normally a diagnostic or therapeutic surgical intervention&#xD;
&#xD;
          -  no distant metastases after routine clinical work up (PET is optional, not mandatory)&#xD;
&#xD;
          -  provision of a written informed consent&#xD;
&#xD;
          -  recent CT-scan of the thorax (&lt;28 days before randomization date)&#xD;
&#xD;
          -  age 18 years or older&#xD;
&#xD;
          -  clinically fit for surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  proof of small cell lung cancer (SCLC) with CWU (bronchoscopy or CT guided&#xD;
             transthoracal punction)&#xD;
&#xD;
          -  stage IV NSCLC&#xD;
&#xD;
          -  patients with a solitary pulmonary nodule (thus without enlarged mediastinal lymph&#xD;
             nodes on CT and without mediastinal PET hot spots) : these do not require further&#xD;
             mediastinal investigation&#xD;
&#xD;
          -  former therapy (chemotherapy or radiotherapy or surgery) for lung cancer&#xD;
&#xD;
          -  other concomitant malignancies&#xD;
&#xD;
          -  reasons for which the patient is unable to swallow the EUS-instrument (e.g. zenker&#xD;
             diverticulum, unexplained esophageal stenosis)&#xD;
&#xD;
          -  uncorrected coagulopathy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kurt Tournoy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
    <description>Website University Hospital Ghent</description>
  </link>
  <verification_date>December 2007</verification_date>
  <study_first_submitted>July 1, 2005</study_first_submitted>
  <study_first_submitted_qc>July 2, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2005</study_first_posted>
  <last_update_submitted>December 19, 2007</last_update_submitted>
  <last_update_submitted_qc>December 19, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

